Following the discovery that CD4+ or CD8+-deficient mice show improved outcome as early as 24 h after reperfusion (Yilmaz et al., 2006), numerous studies have shown the deleterious role of T-lymphocytes in experimental stroke (Malone et al., 2018). This evidence concerns the gene CD8A and Stroke.